SEARCH

SEARCH BY CITATION

References

  • 1
    Dorn CR, Taylor DON and Hibbard HH. Epozootiologic characteristics of canine and feline leukaemia and lymphoma. American Journal of Veterinary Research 1967; 28: 9931001.
  • 2
    Hardy WD. Hematopoietic tumors of cats. Journal of the American Animal Hospital Association 1981; 17: 921940.
  • 3
    Schneider R. Comparison of age- and sex-specific incidence rate patterns of the leukaemia complex in the cat and dog. Journal of the National Cancer Institute 1983; 70: 971977.
  • 4
    Louwerens M, London CA, Pedersen NC and Lyons LA. Feline lymphoma in the post-feline leukaemia virus era. Journal of Veterinary Internal Medicine 2005; 19: 329335.
  • 5
    Ettinger SN. Principles of treatment for feline lymphoma. Clinical Techniques in Small Animal Practice 2003; 18: 98102.
  • 6
    Teske E, van Straten G, van Noort R and Rutteman GR. Chemotherapy with cyclophosphamide, vincristine, and prednisolon (COP) in cats with malignant lymphoma: new results with an old protocol. Journal of Veterinary Internal Medicine 2002; 16: 179186.
  • 7
    Milner RJ, Peyton J, Cooke K, Fox LE, Gallagher A, Gordon P and Hester J. Response rates and survival times for cats with malignant lymphoma treated with the university of Wisconsin-Madison chemotherapy protocol: 38 cases (1996–2003). Journal of the American Veterinary Medical Association 2005; 227: 11181122.
  • 8
    Simon D, Eberle N, Laacke-Singer L and Nolte I. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats. Journal of Veterinary Internal Medicine 2008; 22: 394400.
  • 9
    Teske E, van Lankveld AJ and Rutteman GR. Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma. Veterinary and Comparative Oncology 2014; 12: 3746.
  • 10
    Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA, Frimberger AE and L'Heurex DA. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. Journal of Veterinary Internal Medicine 2001; 15: 348354.
  • 11
    Garrett LD, Thamm DH, Chun R, Dudley R and Vail DM. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. Journal of Veterinary Internal Medicine 2002; 16: 704709.
  • 12
    Simon D, Nolte I, Eberle N, Abbrederis N, Killich M and Hirschberger J. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. Journal of Veterinary Internal Medicine 2006; 20: 948954.
  • 13
    Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A and Shofer F. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Veterinary and Comparative Oncology 2010; 8: 196208.
  • 14
    Burton JH, Garrett-Mayer E and Thamm DH. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Veterinary and Comparative Oncology 2013; 11: 306315.
  • 15
    Mooney SC and Hayes AA. Lymphoma in the cat: an approach to diagnosis and management. Seminars in Veterinary Medicine and Surgery (Small Animal) 1986; 1: 5157.
  • 16
    VCOG. Veterinary Co-operative Oncology Group – Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Veterinary Comparative Oncology 2004; 2: 195213.
  • 17
    Hadden AG, Cotter SM, Rand W, Moore AS, Davis RM and Morrissey P. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats. Journal of Veterinary Internal Medicine 2008; 22: 153157.
  • 18
    Gieger T. Alimentary lymphoma in cats and dogs. Veterinary Clinics of North America: Small Animal Practice 2011; 41: 419432.
  • 19
    Moore AS, Cotter SM, Frimberger AE, Wood CA, Rand WM and LHeureux DA. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. Journal of Veterinary Internal Medicine 1996; 10: 372375.
  • 20
    Kristal O, Lana SE, Ogilvie GK, Rand WM, Cotter SM and Moore AS. Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994–1997). Journal of Veterinary Internal Medicine 2001; 15: 125130.
  • 21
    Mooney SC, Hayes AA, MacEwen EG, Matus RE, Geary A and Shurgot BA. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977–1981). Journal of the American Veterinary Medical Association 1989; 194: 696702.
  • 22
    Vail DM, Moore AS, Ogilvie GK and Volk LM. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. Journal of Veterinary Internal Medicine 1998; 12: 349354.
  • 23
    Taylor SS, Goodfellow MR, Browne WJ, Walding B, Murphy S, Tzannes S, Gerou-Ferriani M, Schwartz A and Dobson JM. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. Journal of Small Animal Practice 2009; 50: 584592.
  • 24
    Jeglum KA, Whereat A and Young K. Chemotherapy of lymphoma in 75 cats. Journal of the American Veterinary Medical Association 1987; 190: 174178.
  • 25
    Krick EL, Cohen RB, Gregor TP, Salah Griessmayr PC and Sorenmo KU. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats. Journal of Veterinary Internal Medicine 2013; 27: 134140.
  • 26
    Zwahlen CH, Lucroy MD, Kraegel SA and Madewell BR. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993–1997). Journal of the American Veterinary Medical Association 1998; 213: 11441149.
  • 27
    Krick EL, Moore RH, Cohen RB and Sorenmo KU. Prognostic significance of weight changes during treatment of feline lymphoma. Journal of Feline Medicine and Surgery 2011; 13: 976983.
  • 28
    Tzannes S, Hammond MF, Murphy S, Sparkes A and Blackwood L. Owners' perception of their cats' quality of life during COP chemotherapy for lymphoma. Journal of Feline Medicine and Surgery 2008; 10: 7381.
  • 29
    Britton BM, Kelleher ME, Gregor TP and Sorenmo KU. Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997–2010). Veterinary Comparative Oncology 2012; doi: 10.1111/vco.12001.
  • 30
    Tunis SR, Stryer DB and Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 2003; 290: 16241632.